Evidence map›Paper›PMID 27881839›Full record

ArticleGenes and immunity2017

A polymorphism in human MR1 is associated with mRNA expression and susceptibility to tuberculosis.

C Seshadri, N T T Thuong, N T H Mai, N D Bang, T T H Chau, D M Lewinsohn, G E Thwaites, S J Dunstan, T R Hawn

Abstract readComparative Study
In one paragraph

Article in Genes and immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. MAIT cells: Conserved watchers on the wall.The Journal of experimental medicine · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. MR1- and HLA-E-Dependent Antigen Presentation ofInternational journal of molecular sciences · 2022
    Review
  16. Article
  17. Article
  18. Offense and Defense in Granulomatous Inflammation Disease.Frontiers in cellular and infection microbiology · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

C SeshadriDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.ORCID 0000-0003-2783-7540
N T T ThuongOxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
N T H MaiHospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
N D BangPham Ngoc Thach Hospital for Tuberculosis and Lung Disease, Ho Chi Minh City, Vietnam.
T T H ChauHospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
D M LewinsohnDivision of Pulmonary and Critical Care Medicine, Oregon Health Sciences University, Portland, OR, USA.
G E ThwaitesOxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
S J DunstanPeter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.ORCID 0000-0001-7873-933X
T R HawnDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
Hospital for Tropical Diseases · VNNuffield Orthopaedic Centre · GBUniversity of Washington · USOregon Health & Science University · USPham Ngoc Thach Hospital · VNThe University of Melbourne · AU

Funding

Innate Immunogenetics & Human InfectionsK24AI089794 · NIAID · UNIVERSITY OF WASHINGTON · PI HAWN, THOMAS R · 2010 to 2014
$746k
The Role of CD1a in Protecting Against Human TuberculosisK08AI089938 · NIAID · UNIVERSITY OF WASHINGTON · PI SESHADRI, CHETAN · 2010 to 2014
$634k
NIAID NIH HHS K08 AI089938NIAID NIH HHS K24 AI089794NIAID NIH HHS L30 AI090891Wellcome Trust 077078Wellcome Trust 089276/Z/09/ZWellcome Trust 206724/Z/17/Z
6 · The paper itself

Abstract

The MR1 antigen-presenting system is conserved among mammals and enables T cells to recognize small molecules produced by bacterial pathogens, including Mycobacterium tuberculosis (M.tb). However, it is not known whether MR1-mediated antigen presentation is important for protective immunity against mycobacterial disease. We hypothesized that genetic control of MR1 expression correlates with clinical outcomes of tuberculosis infection. We performed an MR1 candidate gene association study and identified an intronic single-nucleotide polymorphism (rs1052632) that was significantly associated with susceptibility to tuberculosis in a discovery and validation cohort of Vietnamese adults with tuberculosis. Stratification by site of disease revealed that rs1052632 genotype GG was strongly associated with the development of meningeal tuberculosis (odds ratio=2.99; 95% confidence interval (CI) 1.64-5.43; P=0.00006). Among patients with meningeal disease, absence of the G allele was associated with an increased risk of death (hazard ratio=3.86; 95% CI 1.49-9.98; P=0.005). Variant annotation tools using public databases indicate that rs1052632 is strongly associated with MR1 gene expression in lymphoblastoid cells (P=0.004) and is located within a transcriptional enhancer in epithelial keratinocytes. These data support a role for MR1 in the pathogenesis of human tuberculosis by revealing that rs1052632 is associated with MR1 gene expression and susceptibility to tuberculosis in Vietnam.

Indexed as

Genetic Predisposition to DiseaseAdultBiomarkersCase-Control StudiesFemaleFollow-Up StudiesGenotypeHistocompatibility Antigens Class IHumansMaleMinor Histocompatibility AntigensMycobacterium tuberculosisPolymorphism, Single NucleotidePrognosisRNA, MessengerTuberculosis, PulmonaryBiomarkersHistocompatibility Antigens Class IMinor Histocompatibility AntigensMR1 protein, humanRNA, Messenger

Identifiers

PMID27881839
PMCPMC5269436
OpenAlexW2554124269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.